GLP1(736) regulates somatostatin secretion by modulating calcium channels and influencing changes in membrane potential
Side-effect logging records nausea, fatigue, constipation, and other reactions in detail, helping quickly identify patterns
For weight management, semaglutide (Wegovy) follows a different titration schedule, starting at 0.25 mg and increasing gradually to a maintenance dose of 2.4 mg weekly
Others may need a medication taper, a lower maintenance dose, hormone evaluation, or additional testing
Scientists are now exploring whether therapies originally developed for type 2 diabetes and obesity may influence inflammation, neuronal survival, and the progression of neurodegenerative disorders